(Q46395512)

21 December 2017

title

Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients (English)

1 reference

21 December 2017

1 reference

Mohsen Kerkeni

1

1 reference

21 December 2017

Amel Saïdi

2

1 reference

21 December 2017

Hassan Bouzidi

3

1 reference

21 December 2017

Ahmed Letaief

4

1 reference

21 December 2017

Salim Ben Yahia

5

1 reference

21 December 2017

Mohamed Hammami

6

1 reference

21 December 2017

language of work or name

English

0 references

publication date

22 October 2012

1 reference

21 December 2017

Diabetes and Vascular Disease Research

published in

1 reference

21 December 2017

volume

10

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

239-245

1 reference

21 December 2017

Biochemistry and molecular cell biology of diabetic complications

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Clinical review: The role of advanced glycation end products in progression and complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Advanced glycation: an important pathological event in diabetic and age related ocular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Soluble Receptor for advanced glycation end products (RAGE) is a prognostic factor for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Protein glycation: a firm link to endothelial cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Olmesartan blocks inflammatory reactions in endothelial cells evoked by advanced glycation end products by suppressing generation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Advanced Glycation End Products (AGEs), Oxidative Stress and Diabetic Retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Dissociation between urinary pyrraline and pentosidine concentrations in diabetic patients with advanced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164112460253

21 January 2018

Identifiers

DOI

10.1177/1479164112460253

1 reference

21 December 2017

1 reference

21 December 2017